E. Okada et al., Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients, CANCER LETT, 163(1), 2001, pp. 109-116
One hundred and thirty three gastric cancer cases were investigated immunoh
istochemically to clarify the biological role of survivin in gastric cancer
cells using a commercially available anti-survivin antibody (SURV11A). Fiv
e gastric cancer cell lines were employed to assess localization of survivi
n by reverse-transcription-polymerase chain reaction (RT-PCR) Southern blot
ting, Western blotting and immunofluorescence, signals being found in both
nucleus and cytoplasm. Survivin nuclear staining of gastric cancer cells wa
s evident in 109 of 133 cases (82.0%) and associated with a favorable progn
osis, being an independent prognosticator on multivariate analysis. Survivi
n nuclear positivity also correlated with younger age and lower incidence o
f vessel cancer invasion. In contrast, survivin cytoplasmic positivity was
noted in 117 cases (88.0%) and did not correlate with any factor of progres
sion or prognosis. The results indicate that survivin is present in the maj
ority of gastric cancer cells but a nuclear localization may play an import
ant physiological role in hindering tumor progression. (C) 2001 Elsevier Sc
ience Ireland Ltd. All rights reserved.